{
"raw_text": "```json\n{\n  \"base_id\": \"base_anticoagulation_0160\",\n  \"evaluation\": {\n    \"summary\": \"The patient is a 25-34-year-old male with atrial fibrillation and hypertension, currently on warfarin 5mg daily and aspirin 81mg daily. Vital signs and labs including INR (2.2), creatinine (1.0), and eGFR (85) are within acceptable ranges for anticoagulation management. The INR is within the therapeutic range for atrial fibrillation anticoagulation, suggesting adequate warfarin dosing. Dual therapy with aspirin should be carefully evaluated due to increased bleeding risk, but may be indicated depending on clinical context.\",\n    \"recommendations\": [\n      \"Continue monitoring INR regularly to maintain therapeutic range (2.0-3.0).\",\n      \"Evaluate the indication for concomitant aspirin use as it increases bleeding risk when combined with warfarin; aspirin should be used only if clear clinical indication exists (e.g., recent coronary stenting).\",\n      \"Monitor blood pressure and maintain control of hypertension to reduce stroke risk.\",\n      \"Regular renal function monitoring (currently stable) to adjust warfarin dosing if needed.\",\n      \"Educate patient on signs of bleeding and adherence to medication regimen.\"\n    ],\n    \"risk_assessment\": {\n      \"bleeding_risk\": \"Moderate due to combined warfarin and aspirin therapy\",\n      \"thrombotic_risk\": \"Moderate to high due to atrial fibrillation and hypertension\",\n      \"recommendation\": \"Balance thrombotic and bleeding risks carefully; consider cardiology consultation if dual antithrombotic therapy is questioned.\"\n    }\n  }\n}\n```",
"model_id": "openai",
"version": "gpt-4.1-mini",
"prompt_tokens": 344,
"completion_tokens": 350,
"latency_seconds": 4.8895456000173
}